71. Wang, D-R., Slomski, R. and Cohen, E.P. Leukemia x fibroblast hybrid cells 
prolong the lives of leukemic mice. Eur. J. Cancer Clin. Oncol . 21: 637-644, 
1985. 
72. Fearon. E. R. , Itaya, T., Hunt, B. Vogelstein, B. and Frost, ?. Induction 
in a murine tumor of immunogenic tumor variants by transfection with a foreign 
gene. Cancer Res . 48: 2975-2980, 1988. 
73. Nowak, J., Cohen, E.P. and Graf, Jr., L.H. Cytotoxic activity toward mouse 
melanoma following immunization of mice with transfected cells expressing a 
human melanoma associated antigen. Cancer Irrmunol Immunother . 33: 91-96, 1991. 
74. Hui, K.M., Sim, T.F., Foo, T.T. and Oei, A-A. Tumor rejection mediated by 
transfection with allogeneic class I histocompatibility gene. J. Immunol . 143: 
3835-3843. 1989. 
75. Fearon, E.R., Pardoll, D.M., Itaya, T., Golumbek, P. and Levitsky, H.I. 
Interleukin-2 production by tumor cells bypasses T helper function in the 
generation of an antitumor response. Cell 60: 397-403, 1990. 
76. Gansbacher, B., Bannerji, R. , Daniels, B. Zier, K. Cronin and E. Gilboa. 
Retroviral vector-mediated r-interferon gene transfer into tumor cells 
generates potent and long lasting antitumor immunity. Cancer Res. 50: 7820, 
1990. 
77. Russell, S.J., Eccles, S.A., Flemming, C.L., Johnson, C.A. and Collins, 
M.K.L. Decreased tumorigenicity of a transplantable rat sarcoma following 
transfer and expression of an IL-2 cDNA. Int . J. Cancer 47: 244-251, 1991. 
78. Tepper, R.I., Pattengale, P.K. and Leder, P. Murine IL-4 displays potent 
anti tumor activity in vivo. Cell 57: 503-512, 1989. 
79. Tahara, H., Zen, H., Pappo, I., Nastala, C., Robbins, P.D.and Lotze, M. 
Suppressed growth of murine melanoma in vivo with local secretion of 
interleukin-12 delivered by transfected fibroblasts. Proceedings of the 84th 
Annual Meeting of the American Association of Cancer Research. Abstract number 
2761, 1993. 
80. Golumbek, P.T., Lazenby, A.J., Levitsky, H.I., Jaffee, L.M., Karasuyama, H. 
Baker, M. and Pardoll, D.M. Treatment of established renal cancer by tumor 
cells engineered to secrete interleukin-4. Science 254: 714-716, 1991 
81. Asher, A. I., Mule, J.J., Restifo, N.P., Salo, J.C., Reichert, C.M., Jaffe, 
G., Fendly, B., Kriegler, M. and Rosenberg, S.A. Murine tumor cells transduced 
with the gene for tumor necrosis factor. J. Immunol. 146: 3227-3234,1991. 
82. Dranoff, G., Jaffee, E., Lazenby, A. et al. Vaccination with irradiated 
tumro cells engineered to secrete murine GM-CSF stimulates potent, specific and 
long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. (USA) 90: 35-39, 1993. 
Recombinant DNA Research, Volume 18 
[365] 
